Edwin Veldhuizen obtained his PhD in Biochemistry in 2000, working on the function of the hydrophobic pulmonary surfactant proteins SP-B and SP-C at the Veterinary Faculty of Utrecht University. He then did  a 2-year post-doctoral position in Vancouver in Enzymology, where he characterized the enzymatic activity of recombinantly expressed Homogentisate 1,2 dioxygenate.  After that he got the opportunity to go back to Utrecht University, first as a senior post-doc and later as an assistant professor in the Veterinary Faculty. Here, he studied, and got fascinated by the multiple roles of antimicrobial peptides, especially chicken cathelicidin 2 (CATH-2), with a focus on their immunomodulatory activity. This research has now expanded to multiple porcine AMPs and also other immunomodulatory compounds such as pectins. His research has led to >100 publications (H-index = 43) and he is co-inventor of 5 patents on the use of CATH-2 for veterinary use. Besides that he is a member of the editorial board of three scientific journals,  is involved in teaching veterinary studies and for the Master study of Infectious diseases & Immunology.